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Rabies Vaccine Supply is Limited--Update as of August 22, 2008
The Centers for Disease Control and Prevention (CDC) has been notified by Novartis, maker of RabAvert ® 
(Rabies Vaccine), that the supply of human rabies vaccine is being used at a higher rate than expected, which 
may affect the near-term availability of vaccine for rabies post-exposure prophylaxis (PEP). This development 
follows the August 14 news release by Sanofi Pasteur, which announced the unavailability of the IMOVAX ® 
vaccine until late September-early October. Because of limited existing supplies, the CDC strongly recommends 
that health care providers, state and local public health authorities, animal control officials, and the public take 
immediate steps to ensure appropriate use of human rabies biologics. The Advisory Committee on Immunization 
Practices (ACIP) human rabies prevention recommendations outline animal exposures associated with the risk of 
rabies (http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5703a1.htm). Judicious and appropriate use of rabies 
vaccines is crucial to avert a situation in which persons exposed to rabies are put at increased risk due to 
depleted vaccine supplies.
To ensure that thorough risk assessments are conducted, Novartis is now requiring that health care providers 
confer with public health officials, and obtain a confirmation code from a state health department before ordering 
vaccine doses for post-exposure prophylaxis. Confirmation codes will be updated at a frequent interval. These 
codes should only be released by a state/local health authority that has reviewed the known facts of a given 
exposure and determined they indicate a sufficient level of exposure risk as outlined in the ACIP human rabies 
prevention recommendations (http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5703a1 .htm).
Public health authorities, health care providers, and veterinarians are encouraged to educate the public regarding 
precautions to avoid rabies exposure and actions to take if an exposure occurs. These precautions include 
vaccinating pets and livestock that have close human contact, avoiding stray and wild animals, and safely 
capturing or detaining biting animals (preferably using animal control officials), or obtaining owner contact 
information for follow up. For specific guidance, please see www.cdc.gov/rabies. Persons with possible rabies 
exposure should be evaluated as soon as possible by a health care provider. Since PEP is an urgent medical 
issue but not an emergency, it can be delayed until animal rabies testing or clinical observation is completed. This 
approach not only limits administration of PEP to persons with confirmed rabies exposure, but it is also cost- 
saving and conserves limited resources.
Until vaccine supply levels are restored, distribution of vaccine for pre-exposure prophylaxis (PreP) will continue 
to require approval by state and federal public health authorities. Priority will be given to those individuals with 
occupational rabies exposure risk (e.g., rabies laboratory workers, animal control officers, veterinary staff, wildlife 
workers).
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Discussions among federal, state, and local public health officials are ongoing to review additional strategies to 
manage this situation. A national working group has been convened to monitor the ongoing supply situation and 
provide updated recommendations as the situation evolves.
For more information about rabies and its prevention, and updates regarding vaccine supply, contact your state or 
local public health official or CDC at 1-800-CDC-INFO or visit www.cdc.gov/rabies.
The Centers fo r Disease Control and Prevention (CDC) protects people's health and safety by preventing and 
controlling diseases and in juries; enhances health decisions by providing credible information on critical health 
issues; and promotes healthy living through strong partnerships w ith local, national and international
organizations.
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